News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Germany's Merck KGaA (MKGAF.PK) Looks For Deals To Lift U.S. Drug Sales


11/26/2013 7:53:53 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

German healthcare group Merck KGaA is looking for acquisitions and collaborations with start-ups to grow its drugs business in the United States, a senior Merck official said. The drug and chemicals maker gets some 20 percent of pharmaceutical revenue from the United States, compared with an average of about 50 percent at most global pharma firms. "That's where we want to be," Stefan Oschmann, who heads up Merck's pharmaceutical business, told reporters during a visit to the Merck Serono bio incubator near Tel Aviv on Tuesday.

Help employers find you! Check out all the jobs and post your resume.

Read at Reuters
Read at RTT News


comments powered by Disqus
Reuters
RTT News
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES